{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:35:00Z","timestamp":1787945700267,"version":"build-2784847793"},"reference-count":71,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["R01DA036544-01A1"],"award-info":[{"award-number":["R01DA036544-01A1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institutes of Drug Abuse","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Drug and Alcohol Abuse"],"published-print":{"date-parts":[[2025,11,2]]},"DOI":"10.1080\/00952990.2025.2564757","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T19:41:52Z","timestamp":1765914112000},"page":"761-775","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone"],"prefix":"10.1080","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7784-3987","authenticated-orcid":false,"given":"Azizi","family":"Ray","sequence":"first","affiliation":[{"name":"University of New Mexico Health Sciences Center, Albuquerque"},{"name":"University of Arkansas for Medical Sciences","place":["Little Rock, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-6305","authenticated-orcid":false,"given":"Michael J.","family":"Mancino","sequence":"additional","affiliation":[{"name":"University of Arkansas for Medical Sciences","place":["Little Rock, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9635-5729","authenticated-orcid":false,"given":"Jeff D.","family":"Thostenson","sequence":"additional","affiliation":[{"name":"University of Arkansas for Medical Sciences","place":["Little Rock, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Guise","sequence":"additional","affiliation":[{"name":"University of Arkansas for Medical Sciences","place":["Little Rock, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2151-5911","authenticated-orcid":false,"given":"Howard P.","family":"Hendrickson","sequence":"additional","affiliation":[{"name":"Samford University","place":["Birmingham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2055-3425","authenticated-orcid":false,"given":"Edward V.","family":"Nunes","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8574-230X","authenticated-orcid":false,"given":"Alison H.","family":"Oliveto","sequence":"additional","affiliation":[{"name":"University of Arkansas for Medical Sciences","place":["Little Rock, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"e_1_3_3_2_1","volume-title":"Substance abuse and mental health services","author":"SAMHSA","year":"2021","unstructured":"SAMHSA. Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health (HHS publication No. PEP21-07-01-003, NSDUH series H-56). In: Substance abuse and mental health services. Rockville (MD): Center for Behavioral Health Statistics and Quality; 2021. https:\/\/www.samhsa.gov\/data."},{"key":"e_1_3_3_3_1","unstructured":"CDC W. Atlanta GA: Information and communication wide-ranging online data for epidemiologic research. National Center for Health Statistics; 2020. http:\/\/wonder.cdc.gov."},{"key":"e_1_3_3_4_1","volume-title":"Substance abuse and mental health services administration","author":"SAMHSA","year":"2022","unstructured":"SAMHSA. Preliminary findings from drug-related emergency department visits, 2021; Drug Abuse Warning Network (HHS publication No. PEP22-07-03-001). In: Substance abuse and mental health services administration. Rockville (MD): Center for Behavioral Health Statistics and Quality; 2022. https:\/\/www.samhsa.gov\/data\/."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:122556"},{"key":"e_1_3_3_6_1","unstructured":"NIDA. Fentanyl DrugFacts. National Institute on Drug Abuse website. 2021. https:\/\/nida.nih.gov\/publications\/drugfacts\/fentanyl. June 1 Accessed November 7 2023."},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2010.10400685"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02015.x"},{"key":"e_1_3_3_9_1","first-page":"705","article-title":"Centers for Disease Control and Prevention. Emergency department visits involving nonmedical use of selected prescription drugs - United States, 2004\u20132008","volume":"59","author":"Cai R","year":"2010","unstructured":"Cai R, Crane E, Poneleit K, Paulozzi L. Centers for Disease Control and Prevention. Emergency department visits involving nonmedical use of selected prescription drugs - United States, 2004\u20132008. MMWR Morb Mortal Wkly Rep. 2010;59:705\u2013709.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2010.01.022"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1626"},{"key":"e_1_3_3_12_1","unstructured":"(SAMHSA). S.A.a.M.H.S.A. National survey on drug use and health (NSDUH) state reports 2022. 2022."},{"key":"e_1_3_3_13_1","first-page":"22","article-title":"A pill problem: Prescription drug abuse is the fastest growing form of substance abuse","volume":"36","author":"Hanson K","year":"2010","unstructured":"Hanson K. A pill problem: Prescription drug abuse is the fastest growing form of substance abuse. State Legis. 2010;36:22\u201325.","journal-title":"State Legis"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.05.033"},{"key":"e_1_3_3_15_1","unstructured":"National Institute on Drug A. How effective are medications to treat opioid use disorder? [accessed 2018 6 1; https:\/\/nida.nih.gov\/publications\/research-reports\/medications-to-treat-opioid-addiction\/efficacy-medications-opioid-use-disorder."},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13264"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13024"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep43802"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0708930105"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90386-7"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00634-3"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0033724"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neucli.2004.02.002"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-011-1272-7"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108146"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.2216"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.5302"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.9557056.x"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.70.2.398"},{"key":"e_1_3_3_30_1","first-page":"1","volume-title":"Division of Pfizer Inc","author":"Pfizer","year":"2014","unstructured":"Pfizer. Neurontin - gabapentin [package insert]. In: Parke-Davis D, editor. Division of Pfizer Inc. (NY): Volume LAB-0397-4.0; 2014. p. 1\u201322."},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0866-8"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/13556210500123126"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-085888"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001189"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.34540"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.173823"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.4.689"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.9.1195"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952998709001515"},{"key":"e_1_3_3_40_1","volume-title":"Fyl-1cap156 instructions USA CLIA waived \u2013 product insert","author":"Lochness Medical Supplies I","year":"2022","unstructured":"Lochness Medical Supplies I. Fyl-1cap156 instructions USA CLIA waived \u2013 product insert. Lochness Medical Supplies Inc; 2022."},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2024.2400916"},{"key":"e_1_3_3_42_1","unstructured":"Substance A Mental Health Services A. 2021 National Survey on Drug Use and Health (NSDUH) annual national report. U.S. Department of Health and Human Services; 2023."},{"key":"e_1_3_3_43_1","first-page":"S11","article-title":"Pharmacokinetic properties of current antiepileptic drugs: what improvements are needed?","volume":"55","author":"Bourgeois BF","year":"2000","unstructured":"Bourgeois BF. Pharmacokinetic properties of current antiepileptic drugs: what improvements are needed? Neurology. 2000;55:S11\u20136.","journal-title":"Neurology"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-200007000-00035"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(97)00065-1"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2003.11.020"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31822bb378"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01386-6"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2008.01.013"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp12X653516"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13324"},{"key":"e_1_3_3_52_1","first-page":"S39","article-title":"Mechanisms of action of gabapentin","volume":"153","author":"Taylor CP","year":"1997","unstructured":"Taylor CP. Mechanisms of action of gabapentin. Rev Neurol (Paris). 1997;153 Suppl 1:S39\u201345.","journal-title":"Rev Neurol (Paris)"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.2001.85.6.2388"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90261-2"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)00682-3"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.09.025"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.653426"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.1838"},{"key":"e_1_3_3_59_1","volume-title":"Increases in drug and opioid overdose deaths \u2014 United States, 2000\u20132014","author":"Centers for Disease, C. and Prevention","year":"2015","unstructured":"Centers for Disease, C. and Prevention. Increases in drug and opioid overdose deaths \u2014 United States, 2000\u20132014. 2015."},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000486"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109077"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13069"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.09.003"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15954"},{"key":"e_1_3_3_65_1","first-page":"176","article-title":"Lapse and relapse following inpatient treatment of opiate dependence","volume":"103","author":"Smyth BP","year":"2010","unstructured":"Smyth BP, Barry, J., Keenan, E., Ducray, K.J.I.M.J, Lapse and relapse following inpatient treatment of opiate dependence. Ir Med J. 2010;103:176\u2013179.","journal-title":"Ir Med J"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12862"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2019.1700265"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2007.9.2\/hkleber"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109343"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.02.023"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.9744"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000166"}],"container-title":["The American Journal of Drug and Alcohol Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00952990.2025.2564757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T19:42:04Z","timestamp":1765914124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00952990.2025.2564757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,2]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11,2]]}},"alternative-id":["10.1080\/00952990.2025.2564757"],"URL":"https:\/\/doi.org\/10.1080\/00952990.2025.2564757","relation":{},"ISSN":["0095-2990","1097-9891"],"issn-type":[{"value":"0095-2990","type":"print"},{"value":"1097-9891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iada20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iada20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-10-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}